• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins

    11/5/25 7:00:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $INMD alert in real time by email

    YOKNEAM, Israel, Nov. 5, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter ended September 30, 2025.

    InMode Logo

    Third Quarter 2025 Highlights:

    • Quarterly GAAP revenues of $93.2 million, compared to $130.2 million in the third quarter of 2024, which included $31.9 million of pre-order sales.
    • Quarterly revenues from consumables and service of $19.9 million, an increase of 26% compared to the third quarter of 2024.
    • GAAP operating income of $20.9 million. *Non-GAAP operating income was $23.6 million.
    • Total cash position of $532.3 million as of September 30, 2025, including cash and cash equivalents, marketable securities and short-term bank deposits.

    U.S. GAAP Results

    (U.S. dollars in thousands, except for per share data)



     Q3 2025

     Q3 2024

    Revenues

    $93,165

    $130,232

    (including $31.9M of pre-order sales)

    Gross Margins

    78 %

    82 %

    Net Income

    $21,863

    $50,990

    Earnings per Diluted Share

    $0.34

    $0.65

    *Non-GAAP Results

    (U.S. dollars in thousands, except for per share data)



    Q3 2025

    Q3 2024

    Gross Margins

    78 %

    82 %

    Net Income

    $24,532

    $54,971

    Earnings per Diluted Share

    $0.38

    $0.70



    *Please refer to "Use of Non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements that are included in this release. Non-GAAP results exclude share-based compensation and related tax adjustments.

     

    Management Comments

    "The third quarter progressed in line with our expectations, even as broader economic conditions continued to present challenges," said Moshe Mizrahy, Chief Executive Officer of InMode. "Consumer sentiment remains cautious, and global uncertainties persist. Nonetheless, our team remains focused, executing with discipline and investing in the strategic areas that will fuel our long-term trajectory.

    "On the corporate front, we are excited to welcome Michael Dennison as our new President of North America.  Michael has been with InMode since 2018 and his proven leadership and industry expertise will be instrumental in advancing our regional strategy, deepening customer engagement, and supporting InMode's sustainable growth," Mizrahy concluded.

    Yair Malca, Chief Financial Officer of InMode, added, "Gross margins in the third quarter were in line with expectations and reflected our proactive planning around tariff impacts."

    Third Quarter 2025 Financial Results

    Total revenues for the third quarter of 2025 were $93.2 million.  In the third quarter of 2024, revenues were $130.2 million (including $31.9 million in revenue from first half of 2024 pre-orders). 

    GAAP and a *non-GAAP gross margin for the third quarter was 78%, compared to a gross margin of 82% for the third quarter of 2024.

    GAAP operating margin for the third quarter of 2025 was 22%, compared to 37% in the third quarter of 2024. *Non-GAAP operating margin for the third quarter of 2025 was 25%, compared to 40% for the third quarter of 2024.

    GAAP operating margin for the nine months ended September 30, 2025, was 22% compared to 29% for the same period in 2024. *Non-GAAP operating margin for the nine months ended September 30, 2025, was 26% compared to 33% for the same period in 2024. The decline in operating margins across both the quarterly and year-to-date periods primarily reflects lower sales in the U.S., which is the company's most profitable region.

    InMode reported GAAP net income of $21.9 million, or $0.34 per diluted share, in the third quarter of 2025, compared to $51.0 million, or $0.65 per diluted share, in the third quarter of 2024. On a *non-GAAP basis, InMode reported net income of $24.5 million, or $0.38 per diluted share, in the third quarter of 2025, compared to $55.0 million, or $0.70 per diluted share, in the third quarter of 2024.

    As of September 30, 2025, InMode had cash and cash equivalents, marketable securities and short-term bank deposits of $532.3 million.

    2025 Financial Outlook

    Management provided an outlook for the full year of 2025 ending December 31, 2025. Based on our current estimates, management expects:

    • Revenues remain the same as in previous guidance between $365 million to $375 million
    • *Non-GAAP gross margin remains the same as in previous guidance between 78% and 80%
    • *Non-GAAP income from operations remains the same as in previous guidance to be between $93 million and $98 million
    • *Non-GAAP earnings per diluted share remain the same as in previous guidance between $1.55 to $1.59

    This outlook is not a guarantee of future performance, and stockholders should not rely on such forward-looking statements. See "Forward-Looking Statements" for additional information.

    *Please refer to "Use of Non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements that are included in this release. Non-GAAP results exclude share-based compensation and related tax adjustments.

    The Current Situation in Israel

    Regarding the current situation in Israel, on October 10, 2025, a new cease-fire agreement between Hamas and Israel began, and the hostilities have formally paused after two years of conflicts. The scope and severity of ongoing conflicts in Gaza, Northern Israel, Lebanon, Iran, and the broader region are unpredictable and could escalate any time. To date, our operations have not been materially affected. We continue to monitor political and military developments closely and examine the consequences for our operations and assets. 

    Use of Non-GAAP Financial Measures

    In addition to InMode's operating results presented in accordance with GAAP, this release contains certain non-GAAP financial measures including non-GAAP net income, non-GAAP earnings per diluted share, non-GAAP operating margin. Because these measures are used in InMode's internal analysis of financial and operating performance, management believes they provide investors with greater transparency of its view of InMode's economic performance. Management also believes the presentation of these measures, when analyzed in conjunction with InMode's GAAP operating results, allows investors to more effectively evaluate and compare InMode's performance to that of its peers, although InMode's presentation of its non-GAAP measures may not be strictly comparable to the similarly titled measures of other companies. Schedules reconciling each of these non-GAAP financial measures are provided as a supplement to this release.

    Conference Call Information

    Mr. Moshe Mizrahy, Chief Executive Officer, Dr. Michael Kreindel, Co-Founder and Chief Technology Officer, Mr. Yair Malca, Chief Financial Officer will host a conference call today, November 5, 2025, at 8:30 a.m. Eastern Time to discuss the third quarter 2025 financial results.

    The Company encourages participants to pre-register for the conference call using the following link: 

    https://dpregister.com/sreg/10202681/ffd9babcf8. Callers will receive a unique dial-in number upon registration, which enables immediate access to the call. Participants may pre-register at any time, including up to and after the call start time.

    For callers who opt out of pre-registration, please dial one of the following teleconferencing numbers. Please begin by placing your call 10 minutes before the conference call commences. If you are unable to connect using the toll-free number, please try the international dial-in number.

    U.S. Toll-Free Dial-in Number: 1-833-316-0562

    Israel Toll- Free Dial-in Number: 1-80-921-2373

    International Dial-in Number: 1-412-317-5736

    Webcast URL: https://event.choruscall.com/mediaframe/webcast.html?webcastid=JfIdKlTZ

    At:

    8:30 a.m. Eastern Time

    5:30 a.m. Pacific Time

    The conference call will also be webcast live from a link on InMode's website at https://inmodeinvestors.com/events-presentations/. A replay of the conference call will be available from November 5, 2025, at 12 p.m. Eastern Time to November 19, 2025, at 11:59 p.m. Eastern Time. To access the replay, please dial one of the following numbers: 

    Replay Dial-in U.S TOLL-FREE: 1-877-344-7529

    Replay Dial-in Canada TOLL-FREE: 1-855-669-9658

    Replay Dial-in TOLL/INTERNATIONAL: 1-412-317-0088

    Replay Pin Number: 2676014

    To access the replay using an international dial-in number, please select the link below:

    https://services.choruscall.com/ccforms/replay.html

    A replay of the conference call will also be available for 90 days on InMode's website at https://inmodeinvestors.com/events-presentations/.

    About InMode

    InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

    Forward-Looking Statements

    The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the 2025 revenue projection described above. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 4, 2025, and our future public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.

    Company Contact:

    Yair Malca

    Chief Financial Officer

    Phone: (949) 305-0108

    Email: [email protected] 

    Investor Relations Contact:

    Miri Segal

    MS-IR LLC

    Email: [email protected] 

     

    INMODE LTD.

    CONDENSED CONSOLIDATED STATEMENTS OF INCOME

    (U.S. dollars in thousands, except for per share data)

    (Unaudited)





    Three months ended

    September 30,



    Nine months ended

    September 30,



    2025



    2024



    2025



    2024



    REVENUES

    93,165



    130,232



    266,641



    296,965



    COST OF REVENUES

    20,856



    24,055



    56,971



    57,536



    GROSS PROFIT

    72,309



    106,177



    209,670



    239,429



    OPERATING EXPENSES:

















    Research and development

    3,543



    3,254



    9,810



    10,470



    Sales and marketing

    44,970



    51,863



    132,171



    136,713



    General and administrative

    2,899



    2,799



    8,293



    7,579



    TOTAL OPERATING EXPENSES

    51,412



    57,916



    150,274



    154,762



    OPERATIONS INCOME

    20,897



    48,261



    59,396



    84,667



    Finance income, net

    4,721



    9,918



    19,642



    26,592



    INCOME BEFORE INCOME TAXES

    25,618



    58,179



    79,038



    111,259



    INCOME TAXES

    3,755



    7,189



    12,232



    12,755



    NET INCOME

    21,863



    50,990



    66,806



    98,504





















    EARNINGS PER SHARE:

















    Basic

    0.35



    0.66



    1.03



    1.20



    Diluted

    0.34



    0.65



    1.02



    1.19



    WEIGHTED AVERAGE NUMBER OF SHARES

    OUTSTANDING USED IN COMPUTATION OF

    EARNINGS PER SHARE (in thousands)

















    Basic

    63,291



    77,022



    65,072



    81,795



    Diluted

    63,868



    77,908



    65,727



    83,016



     

    INMODE LTD.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (U.S. dollars in thousands, except for per share data)

    (Unaudited)





    September 30,

    2025



    December 31,

    2024

    Assets







    CURRENT ASSETS:







    Cash and cash equivalents

    252,437



    155,329

    Marketable securities

    121,518



    267,688

    Short-term bank deposits

    158,353



    173,455

    Accounts receivable, net of allowance for credit losses

    38,095



    36,335

    Prepaid expense and other receivables

    24,485



    22,097

    Inventories

    71,403



    59,548

         TOTAL CURRENT ASSETS

    666,291



    714,452

        NON-CURRENT ASSETS:







    Accounts receivable, net of allowance for credit losses

    2,350



    3,176

    Deferred income tax asset

    54,104



    56,285

    Operating lease right-of-use assets

    8,922



    8,732

    Property and equipment, net

    2,238



    2,322

    Other investments

    700



    700

    TOTAL NON-CURRENT ASSETS

    68,314



    71,215

    TOTAL ASSETS

    734,605



    785,667

    Liabilities and shareholders' equity







    CURRENT LIABILITIES:







    Accounts payable

    16,723



    13,782

    Contract liabilities

    15,099



    16,755

    Other liabilities

    36,508



    39,314

    TOTAL CURRENT LIABILITIES

    68,330



    69,851

        NON-CURRENT LIABILITIES:







    Contract liabilities

    3,126



    3,336

    Other liabilities

    4,171



    3,356

    Operating lease liabilities

    5,593



    5,311

    TOTAL NON-CURRENT LIABILITIES

    12,890



    12,003

    TOTAL LIABILITIES

    81,220



    81,854









    TOTAL SHAREHOLDERS' EQUITY

    653,385



    703,813

    TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

    734,605



    785,667

     

    INMODE LTD.

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (U.S. dollars in thousands, except for per share data)

    (Unaudited)







    Three months ended

    September 30,



    Nine months ended

    September 30,



    2025



    2024



    2025



    2024



    CASH FLOWS FROM OPERATING ACTIVITIES:

















    Net income

    21,863



    50,990



    66,806



    98,504



    Adjustments required to reconcile net income to net cash provided by operating activities:

















    Depreciation and amortization

    156



    138



    521



    480



    Share-based compensation expenses

    2,696



    3,981



    8,632



    13,122



    Change in allowance for credit losses of trade receivable

    106



    130



    159



    414



    Loss on marketable securities, net

    11



    29



    14



    170



    Finance expenses (income), net

    3,147



    3,863



    1,260



    (5,934)



    Deferred income taxes

    602



    35



    2,064



    (58)



    Changes in operating assets and liabilities:

















    Decrease (increase) in accounts receivable

    (2,353)



    (2,570)



    (1,094)



    1,924



    Increase in other receivables

    (147)



    (860)



    (2,403)



    (7,577)



    Increase in inventories

    (3,293)



    (5,657)



    (11,855)



    (13,189)



    Increase (decrease) in accounts payable

    (759)



    (1,235)



    2,941



    347



    Increase (decrease) in other liabilities

    564



    11,722



    (2,596)



    6,160



    Increase (decrease) in contract liabilities (current and non-current)

    1,874



    (26,517)



    (1,866)



    5,859



    Net cash provided by operating activities

    24,467



    34,049



    62,583



    100,222



    CASH FLOWS FROM INVESTING ACTIVITIES:

















    Investment in short-term deposits

    (153,904)



    (78,390)



    (178,904)



    (164,687)



    Proceeds from short-term deposits

    103,390



    138,140



    189,687



    151,640



    Purchase of fixed assets

    (134)



    (77)



    (438)



    (435)



    Purchase of marketable securities

    -



    (90,820)



    (20,877)



    (276,513)



    Proceeds from sale of marketable securities

    14,211



    22,233



    17,214



    69,608



    Proceeds from maturity of marketable securities

    48,105



    122,969



    152,127



    304,777



    Net cash provided by investing activities

    11,668



    114,055



    158,809



    84,390



    CASH FLOWS FROM FINANCING ACTIVITIES:

















     Repurchase of ordinary shares

    -



    (76,556)



    (127,444)



    (165,536)



        Exercise of options

    249



    565



    1,248



    1,194



    Net cash provided by (used in) financing activities

    249



    (75,991)



    (126,196)



    (164,342)



    EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS

    (184)



    728



    1,912



    157



    NET INCREASE IN CASH AND CASH EQUIVALENTS

    36,200



    72,841



    97,108



    20,427





















    CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD

    216,237



    91,997



    155,329



    144,411



    CASH AND CASH EQUIVALENTS AT END OF PERIOD

    252,437



    164,838



    252,437



    164,838



     

    INMODE LTD.

    CONDENSED CONSOLIDATED FINANCIAL HIGHLIGHTS

    (U.S. dollars in thousands, except for per share data)

    (Unaudited)



     

    Three months ended September 30, 



    Nine months ended September 30,

    2025





     

    2024



    2025





     

    2024

     

    Revenues by Category: 































    Capital Equipment revenues - United States

    45,203



    49 %



    85,734



    66 %



    1,15,398



    44 %



    1,51,392



    51 %

    Capital Equipment revenues - International

    28,063



    30 %



    28,662



    22 %



    91,329



    34 %



    86,191



    29 %

     

    Total Capital Equipment revenues 

     

    73,266



     

    79 %



     

    1,14,396



     

    88 %



     

    2,06,727



     

    78 %



     

    2,37,583



     

    80 %

    Consumables and service revenues

    19,899



    21 %



    15,836



    12 %



    59,914



    22 %



    59,382



    20 %

     

    Total Revenue 

     

    93,165



     

    100 %



     

    1,30,232



     

    100 %



     

    2,66,641



     

    100 %



     

    2,96,965



     

    100 %

     



    Three months ended September 30,



    Nine months ended September 30,

    2025



    2024



    2025



    2024



    %



    %



    %



    %



    United

    States



    International



    Total



    United

    States



    International



    Total



    United

    States



    International



    Total



    United

    States



    International



    Total

    Revenues by Technology:















































    Minimal-Invasive

    75



    76



    75



    95



    77



    90



    79



    79



    80



    90



    82



    88

    Hands-Free

    2



    1



    2



    4



    3



    4



    3



    2



    2



    7



    3



    5

    Non-Invasive

    23



    23



    23



    1



    20



    6



    18



    19



    18



    3



    15



    7



    100



    100



    100



    100



    100



    100



    100



    100



    100



    100



    100



    100

     

    INMODE LTD.



    RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF

    INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME 

    (U.S. dollars in thousands, except for per share data)

     (Unaudited)

     







    Three months ended September 30, 2025



    Three months ended September 30, 2024





    GAAP



    Share Based

    Compensation



    Non-GAAP



    GAAP



    Share Based

    Compensation



    Non-GAAP



    REVENUES

    93,165



    -



    93,165



    130,232



    -



    130,232



    COST OF REVENUES

    20,856



    (343)



    20,513



    24,055



    (481)



    23,574



    GROSS PROFIT

    72,309



    343



    72,652



    106,177



    481



    106,658



    OPERATING EXPENSES:

























    Research and development

    3,543



    (274)



    3,269



    3,254



    (890)



    2,364



    Sales and marketing

    44,970



    (1,804)



    43,166



    51,863



    (2,300)



    49,563



    General and administrative

    2,899



    (275)



    2,624



    2,799



    (310)



    2,489



    TOTAL OPERATING

    EXPENSES

    51,412



    (2,353)



    49,059



    57,916



    (3,500)



    54,416



    OPERATIONS INCOME

    20,897



    2,696



    23,593



    48,261



    3,981



    52,242



    Finance income, net

    4,721



    -



    4,721



    9,918



    -



    9,918



    INCOME BEFORE INCOME TAXES

    25,618



    2,696



    28,314



    58,179



    3,981



    62,160



    INCOME TAXES

    3,755



    27



    3,782



    7,189



    -



    7,189



    NET INCOME

    21,863



    2,669



    24,532



    50,990



    3,981



    54,971



    EARNINGS PER SHARE:

























    Basic

    0.35







    0.39



    0.66







    0.71



    Diluted

    0.34







    0.38



    0.65







    0.70



    WEIGHTED AVERAGE NUMBER OF

    SHARES OUTSTANDING USED IN

    COMPUTATION OF EARNINGS PER

    SHARE (in thousands)

























    Basic

    63,291







    63,291



    77,022







    77,022



    Diluted

    63,868







    64,531



    77,908







    78,548



     



    Nine months ended September 30, 2025



    Nine months ended September 30, 2024

    GAAP



    Share Based

    Compensation



    Non-GAAP



    GAAP



    Share Based

    Compensation



    Non-GAAP

    REVENUES

    266,641



    -



    266,641



    296,965



    -



    296,965

    COST OF REVENUES

    56,971



    (987)



    55,984



    57,536



    (1,361)



    56,175

    GROSS PROFIT

    209,670



    987



    210,657



    239,429



    1,361



    240,790

    OPERATING EXPENSES:























    Research and development

    9,810



    (783)



    9,027



    10,470



    (1,877)



    8,593

    Sales and marketing

    132,171



    (6,096)



    126,075



    136,713



    (9,007)



    127,706

    General and administrative

    8,293



    (766)



    7,527



    7,579



    (877)



    6,702

    TOTAL OPERATING

    EXPENSES

    150,274



    (7,645)



    142,629



    154,762



    (11,761)



    143,001

    OPERATIONS INCOME

    59,396



    8,632



    68,028



    84,667



    13,122



    97,789

    Finance income, net

    19,642



    -



    19,642



    26,592



    -



    26,592

    INCOME BEFORE INCOME

    TAXES

    79,038



    8,632



    87,670



    111,259



    13,122



    124,381

    INCOME TAXES

    12,232



    (628)



    11,604



    12,755



    -



    12,755

    NET INCOME

    66,806



    9,260



    76,066



    98,504



    13,122



    111,626

    EARNINGS PER

    SHARE:























    Basic

    1.03







    1.17



    1.20







    1.36

    Diluted

    1.02







    1.15



    1.19







    1.34

    WEIGHTED AVERAGE

    NUMBER OF SHARES

    OUTSTANDING USED IN

    COMPUTATION OF

    EARNINGS PER SHARE (in

    thousands)























    Basic

    65,072







    65,072



    81,795







    81,795

    Diluted

    65,727







    66,199



    83,016







    83,536

     

    Logo: https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

     

    Cision View original content:https://www.prnewswire.com/news-releases/inmode-reports-third-quarter-2025-financial-results-quarterly-revenue-of-93-2-million-78-gross-margins-302605384.html

    SOURCE InMode Ltd.

    Get the next $INMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $INMD

    DatePrice TargetRatingAnalyst
    4/29/2025Buy → Neutral
    BTIG Research
    4/28/2025$22.00 → $16.00Outperform → Neutral
    Robert W. Baird
    10/17/2024$25.00Buy
    BTIG Research
    7/23/2024$21.00 → $19.00Buy → Hold
    Jefferies
    11/3/2023$52.00 → $24.00Buy → Neutral
    UBS
    10/13/2023$55.00 → $22.00Buy → Hold
    Canaccord Genuity
    3/29/2023$40.00Buy
    UBS
    2/17/2023Buy → Hold
    Needham
    More analyst ratings

    $INMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    InMode downgraded by BTIG Research

    BTIG Research downgraded InMode from Buy to Neutral

    4/29/25 8:06:22 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    InMode downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded InMode from Outperform to Neutral and set a new price target of $16.00 from $22.00 previously

    4/28/25 1:56:11 PM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    BTIG Research initiated coverage on InMode with a new price target

    BTIG Research initiated coverage of InMode with a rating of Buy and set a new price target of $25.00

    10/17/24 7:41:34 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $INMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins

    YOKNEAM, Israel, Nov. 5, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights: Quarterly GAAP revenues of $93.2 million, compared to $130.2 million in the third quarter of 2024, which included $31.9 million of pre-order sales.Quarterly revenues from consumables and service of $19.9 million, an increase of 26% compared to the third quarter of 2024.GAAP operating income of $20.9 million. *Non-GAAP operating income was $23.6 million.Total cash position of $532.3 million as of September 30, 2025, incl

    11/5/25 7:00:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    InMode Appoints Michael Dennison as President of North America

    IRVINE, Calif., Nov. 3, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, has appointed Michael Dennison, most recently Vice President of Sales, as President of North America.  Dennison has held nearly every sales position in the aesthetic medical device industry, consistently producing at the highest level in each. With close to a decade of leadership experience at InMode, Dennison has advanced through roles from District Sales Manager to Vice President of Sales, driving national revenue growth, expanding market shar

    11/3/25 8:05:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    InMode to Participate in Upcoming Investor Conferences

    YOKNEAM, Israel, Oct. 30, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, today announced the participation in the following investor conferences in November: UBS Global Healthcare Conference Presenter: Yair Malca, Chief Financial Officer Format: In-person one-on-one meetings Location: Palm Beach Gardens, FL When: Monday, November 10 Jefferies Global Healthcare Conference Presenter: Moshe Mizrahy, Chief Executive Officer Format: In-person fireside chat moderated by Matt Taylor, Senior Equity Analyst, and one-on-one meetings Location: London, U.K. When: Tuesday, November 18, Fireside Chat at 4:00 pm GMT A live webcast of the prese

    10/30/25 8:30:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $INMD
    SEC Filings

    View All

    SEC Form 6-K filed by InMode Ltd.

    6-K - InMode Ltd. (0001742692) (Filer)

    11/5/25 7:00:08 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 6-K filed by InMode Ltd.

    6-K - InMode Ltd. (0001742692) (Filer)

    9/18/25 7:30:09 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 6-K filed by InMode Ltd.

    6-K - InMode Ltd. (0001742692) (Filer)

    7/30/25 7:01:14 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $INMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by InMode Ltd. (Amendment)

    SC 13G/A - InMode Ltd. (0001742692) (Subject)

    2/13/24 4:31:18 PM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G/A filed by InMode Ltd. (Amendment)

    SC 13G/A - InMode Ltd. (0001742692) (Subject)

    2/13/24 4:25:40 PM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G filed by InMode Ltd.

    SC 13G - InMode Ltd. (0001742692) (Subject)

    2/6/24 9:36:39 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $INMD
    Financials

    Live finance-specific insights

    View All

    InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins

    YOKNEAM, Israel, Nov. 5, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights: Quarterly GAAP revenues of $93.2 million, compared to $130.2 million in the third quarter of 2024, which included $31.9 million of pre-order sales.Quarterly revenues from consumables and service of $19.9 million, an increase of 26% compared to the third quarter of 2024.GAAP operating income of $20.9 million. *Non-GAAP operating income was $23.6 million.Total cash position of $532.3 million as of September 30, 2025, incl

    11/5/25 7:00:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    InMode to Report Third Quarter 2025 Financial Results and Hold Conference Call on November 5, Expects Q3 Revenue Between $92.5M-$93.0M, Reiterates FY 2025 Guidance Between $365M-$375M

    Conference call to be held on Wednesday, November 5, 2025, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Oct. 9, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the third quarter 2025 before the Nasdaq market opens on Wednesday, November 5, 2025. InMode is currently finalizing its financial results for the third quarter of 2025. While complete financial information and operating data are not yet available, set forth below are certain preliminary results of InMode's financial results for such period, subject to final adjustments and other developments that may aris

    10/9/25 7:00:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Return Capital to the Shareholders

    Believes the Board Should Approve and Execute a 10% Buyback in Q4 2025 and Another 10% Buyback in Q1 2026 Maintains Board Has Legal and Fiduciary Duty to Act in Best Interests of Shareholders  MIAMI, Sept. 9, 2025 /PRNewswire/ -- DOMA Perpetual Capital Management LLC, a significant stockholder of InMode Ltd. (NYSE: INMD) ("InMode"), today sent a letter to the Board of Directors of InMode (the "Board") urging the Board to return capital to shareholders.  The letter can be downloaded here The full text of the letter follows: September 9th, 2025 To the Board Members of InMode: In

    9/9/25 8:15:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $INMD
    Leadership Updates

    Live Leadership Updates

    View All

    InMode Appoints Michael Dennison as President of North America

    IRVINE, Calif., Nov. 3, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, has appointed Michael Dennison, most recently Vice President of Sales, as President of North America.  Dennison has held nearly every sales position in the aesthetic medical device industry, consistently producing at the highest level in each. With close to a decade of leadership experience at InMode, Dennison has advanced through roles from District Sales Manager to Vice President of Sales, driving national revenue growth, expanding market shar

    11/3/25 8:05:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care